Latest stories on PRME
Prime Medicine (PRME) Reaches Positive Resolution to Arbitration with Beam Therapeutics
Yahoo Top65 · bullishgeneral
Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable
Seeking Alpha56 · neutralgeneral
PRME Surges 15% After Winning Arbitration Against Beam — Clears Path To Human Trials For Its Gene-Editing Drug
Stocktwits News73 · bullishgeneral
Prime Medicine Secures Arbitration Win, Paving Way for PM647 Clinical Advances—Key Dates and Pipeline Focus Stand Out
July 8, 2026
MarketChameleon67 · bullishproduct/pr
Prime Medicine gains after winning arbitration with Beam Therapeutics
Seeking Alpha67 · bullishgeneral
Prime Medicine resolves arbitration, clarifying PM647 development rights
TipRanks56 · neutralgeneral
Prime Medicine, Inc. (PRME) files 8-K
SEC 8-K50 · neutralgeneral
Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics | PRME Stock News
StockTitan67 · bullishgeneral
Here’s Why H.C. Wainwright Upgraded Prime Medicine (PRME) To “Buy”
Yahoo Top63 · neutralanalyst
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool54 · neutralanalyst
Prime Medicine's Prime Editing Is Worth The Risk
Seeking Alpha63 · neutralanalyst
Prime Medicine, Inc. (PRME) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Prepared Remarks Transcript
Seeking Alpha55 · neutralgeneral
Prime Medicine Stockholders Reaffirm Board and Auditor Choices
TipRanks50 · neutralgeneral
Prime Medicine, Inc. (PRME) files 8-K
SEC 8-K50 · neutralgeneral
Prime Medicine, Inc. (PRME) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference | PRME Stock News
StockTitan55 · neutralgeneral
Prime Medicine to Present at Jefferies Global Healthcare Conference | PRME Stock News
StockTitan55 · neutralgeneral